Showing results (21-30 of 49) with videos related to
Sort By:
Pageof 5
Journal of Surgical Oncology|July 21, 2015
Prognostic significance of DNA cytometry for adjuvant therapy response in pancreatic cancerFritz Klein, Marcus Bahra, Anja Schirmeier, et al.BMC Cancer|December 6, 2008
Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy)Hanno Riess, Uwe Pelzer, Andreas Hilbig, et al.Cancer Chemotherapy and Pharmacology|March 15, 2011
First-line treatment of pancreatic cancer patients with the combination of 5-fluorouracil/folinic acid plus gemcitabine: a multicenter phase II trial by the CONKO-study groupUwe Pelzer, Dirk Arnold, Peter Reitzig, et al.The Journal of Pathology. Clinical Research|May 15, 2024
KRT81 and HNF1A expression in pancreatic ductal adenocarcinoma: investigation of predictive and prognostic value of immunohistochemistry-based subtypingJia Rao, Marianne Sinn, Uwe Pelzer, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|July 13, 2005
Changing impact of cytomegalovirus in liver transplantation -- a single centre experience of more than 1000 transplantations without ganciclovir prophylaxisDaniel Seehofer, Nada Rayes, Ulf P Neumann, et al.European Journal of Cancer (Oxford, England : 1990)|May 3, 2021
Impact of completeness of adjuvant gemcitabine, relapse pattern, and subsequent therapy on outcome of patients with resected pancreatic ductal adenocarcinoma - A pooled analysis of CONKO-001, CONKO-005, and CONKO-006 trialsAnnika Kurreck, Johanna Weckwerth, Dominik P Modest, et al.Onkologie|June 24, 2009
[Diagnosis and treatment of liver metastases from primary colorectal tumour]Dirk Arnold, Ernst J Rummeny, Thomas Kirchner, et al.JAMA|October 10, 2013
Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trialHelmut Oettle, Peter Neuhaus, Andreas Hochhaus, et al.British Journal of Cancer|May 15, 2018
Tumour buds determine prognosis in resected pancreatic ductal adenocarcinomaPhilipp Lohneis, Marianne Sinn, Fritz Klein, et al.Journal of Clinical Medicine|August 26, 2022
Dual Targeting of the EGFR/HER2 Pathway in Combination with Systemic Chemotherapy in Refractory Pancreatic Cancer-The CONKO-008 Phase I InvestigationJana K Striefler, Jens M Stieler, Christopher C M Neumann, et al.Pageof 5